Repligen (RGEN) Cash from Operations Growth (5y) (2015 - 2026)
Repligen (RGEN) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.54 Bn | 121.33 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.82 Bn | 44.00 Bn | 2.15 Bn |
| 3 | Alcon | 32.93 Bn | 31.28 Bn | 1.53 Bn |
| 4 | Medline | 32.92 Bn | 30.68 Bn | 1.84 Bn |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.40 Bn | 22.97 Bn | 329.20 Mn |
| 7 | Solventum | 14.04 Bn | 13.48 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.79 Bn | 13.65 Bn | 735.40 Mn |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn |
| 10 | Repligen | 7.40 Bn | 6.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.03% |
| Dec 31, 2025 | 11.57% |
| Sep 30, 2025 | 17.49% |
| Jun 30, 2025 | 11.32% |
| Mar 31, 2025 | 9.50% |
| Dec 31, 2024 | 17.26% |
| Sep 30, 2024 | 17.56% |
| Jun 30, 2024 | 18.85% |
| Mar 31, 2024 | 35.50% |
| Dec 31, 2023 | 39.23% |
| Sep 30, 2023 | 14.79% |
| Jun 30, 2023 | 42.03% |
| Mar 31, 2023 | 47.98% |
| Dec 31, 2022 | 32.39% |
| Sep 30, 2022 | 91.77% |
| Jun 30, 2022 | 74.65% |
| Mar 31, 2022 | 82.33% |
| Dec 31, 2021 | 90.96% |
| Sep 30, 2021 | 83.77% |
| Jun 30, 2021 | 28.94% |